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Objective: Abdominal surgery in patients with advanced liver disease has been reported to be associated with high
morbidity and mortality rates. However, the surgical risk of infrarenal abdominal aortic aneurysm (AAA) repair in
cirrhotics remains ill-defined. We reviewed our experience to investigate the predictors of the outcome in cirrhotic
patients after elective AAA open repair.
Methods: Between January 2001 andMarch 2006, 1189 patients underwent elective open repair of infrarenal AAA and 24
(2%) had a biopsy-proven cirrhosis (23 male, 1 female; mean age, 68  7 years). The latter were retrospectively stratified
according to the Child-Turcotte-Pugh (CTP) score and theModel for End-Stage Liver Disease (MELD) score. Operative
variables, perioperative complications, and survival were recorded and compared with those of 48 concurrent noncir-
rhotic controls matched (2:1) by gender, age, aneurysm size, preoperative glomerular filtration rate, and type of
reconstruction. The effect of CTP and MELD scores on midterm survival was investigated in cirrhotics with the
Kaplan-Meier log-rank method.
Results: No intraoperative or 30-day deaths were recorded. No significant differences in terms of major perioperative
complications were observed between cirrhotic patients and controls. Operative time and intraoperative blood transfu-
sion requirement were significantly higher in cirrhotics (162 49 vs 132 39 minutes; P .007 and 273 364 vs 84
183 mL; P .040, respectively). Hospital length of stay was nearly doubled in cirrhotic patients (11.0 2.8 vs 5.8 1.5
days; P < .0001). Twenty-two cirrhotic patients were classified as CTP A and two as CTP B. Median MELD score was
8 (range, 6-14). CTP class B was associated with higher intraoperative blood transfusion requirement (941 54 vs 213
314 mL; P  .029). At a mean follow-up of 30.7  22.1 months, five deaths were recorded in cirrhotics, and three in
controls. Actuarial survival at 2 years was 77.4% in cirrhotics and 97.8% in controls (log-rank test, P  .026). Both CTP
B patients died within 6months. CTP class B and aMELD score>10were associated with reducedmidterm survival rates
(log-rank test, P < .0001 and P  .021, respectively).
Conclusions: In our experience, elective AAA open repair in relatively compensated cirrhotics was safely performed with an
acceptable increase of the magnitude of the operation. However, the reduced life expectancy of cirrhotics with a MELD score
>10 suggests that such a procedure may not be warranted in this subgroup of patients. (J Vasc Surg 2011;53:906-11.)
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MSurgery and associated anesthesia have deranging effects
on patients with advanced liver disease that may entail in-
creased perioperative morbidity and mortality rates.1 Also,
specific complications associated with cirrhosis, including co-
agulopathy, thrombocytopenia, varices, and ascites, signifi-
cantly increase the magnitude of the operation and may ad-
versely affect the outcome.2,3 A number of studies have
previously investigated the surgical risk of nonhepatic surgical
procedures in cirrhotics, but the reported results largely differ
due to the great variety of the considered operations, and the
degree of patients’ liver dysfunction.2-7
The literature regarding the management of abdominal
aortic aneurysm (AAA) in patients with advanced liver disease
is scant, andoperative risks remain amatter of debate. A recent
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906ata analysis on the Nationwide Inpatient Sample, the largest
npatient care database in the U.S., reported a five-fold in-
rease risk of in-hospital death in patients with compensated
irrhosis.4 Yet, this study had several limitations typically in-
erent to the use of administrative data8 and admittedly did
ot employ established risk stratification systems for liver
isease. In this respect, the stratification of surgical risk in
irrhotics is traditionally based on the Child-Turcotte-Pugh
CTP) score that, however, has significant drawbacks related
o the subjective assessment of some parameters, and their
imited discriminant power. As an alternative, amore objective
rognostic score, named the Model for End-Stage Liver Dis-
ase (MELD), is currently used both as a predictor of opera-
ive risks2,9,10 and as a component of the organ allocation
olicy for orthotopic liver transplantation.11 Notably, the
ELD has never been employed as a prognostic score in
atients with AAA.
In this study, we analyzed our experience to evaluate the
utcomeof conventional open repair ofAAA in cirrhotics, and
o identify the influence of the specific prognostic scores for
atients with advanced liver disease.
ETHODS
A retrospective review was conducted on a prospec-
ively compiled computerized database of all patients sub-
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Volume 53, Number 4 Marrocco-Trischitta et al 907mitted to elective AAA open repair at our Center between
January 2001 and March 2006. During this period, 24
patients with a biopsy proven cirrhosis were referred to us
for a concomitant AAA. There were 23 men and one
woman, with a mean age of 68 7 years. All patients were
considered fit for surgery and operated on electively. Based
on patients’ preoperative assessment of liver function, and
routine intraoperative liver inspection and palpation, no
records of other cirrhotic patients were found in our data-
base. Surgery was performed through a transperitoneal
approach, and intravenous heparin (70 IU/kg) was admin-
istered before aortic cross-clamping. Aortic reconstruction
was performed with Dacron graft interposition, and proxi-
mal and distal anastomoses were made in an end-to-end
fashion.
Forty-eight matched controls (2:1) were randomly
identified from the database among concurrent 1165 non-
cirrhotic controls. Matching was by gender, age (5 years),
AAA diameter (5mm), preoperative glomerular filtration
rate (GFR; 10 mL/dL/1.73 m2), and type of aortic
reconstruction.
Patient groups were stratified by preoperative risk fac-
tors including diabetes, tobacco use, hypertension, and
hyperlipidemia using a simplified grading system according
to the Society for Vascular Surgery Suggested Reporting
Standards; by perioperative cardiac risk, according to the
Goldman’s Revised Cardiac Risk Index; and by glomerular
filtration rate (GFR), estimated by using the Cockcroft-
Gault equation, as previously described in detail.12
Cirrhotics were further stratified according to the CTP
(Table I), and the MELD score that includes the interna-
tional normalized ratio (INR), serum creatinine, and serum
bilirubin.13 The original mathematical formula is:
9.57 loge(creatinine) 3.78 loge(total bilirubin
Table I. Child-Turcotte-Pugh score
Criteria
Total serum bilirubin 2 mg/dL: 1 point
2-3 mg/dL: 2 points
3 mg/dL: 3 points
Serum albumin 3.5 g/dL: 1 point
2.8 to 3.5 g/dL: 2 points
2.8 g/dL: 3 points
International Normalized Ratio 1.70: 1 point
1.71-2.20: 2 points
2.20: 3 points
Ascites Absence: 1 point
Controlled medically: 2 points
Poorly controlled: 3 points
Encephalopathy Absence: 1 point
Controlled medically: 2 points
Poorly controlled: 3 points
Child classes
A 5-6 points
B 7-9 points
C 10-15 points 11.2 loge(INR) 6.43 pinimal values are set to 1.0 for calculation purposes. The
aximal serum creatinine level considered is 4.0 mg/dL.14
he score varies from 6 to 40 and can be calculated with an
nline worksheet provided by the Mayo Clinic at http://
ww.mayoclinic.org/gi-rst/mayomodel5.html.
Morbidity and mortality were recorded in both patient
roups. Liver dysfunction was defined as both prothrombin
ime50% and serum bilirubin level5 mg/100 mL for 3
r more consecutive days.15 The normal serum creatinine
as defined as 1.5 mg/dL. Renal dysfunction was de-
ned as a rise in serum creatinine exceeding the baseline
alue by 30% and surpassing an absolute level of 2.0 mg/
L.16 Myocardial infarction was suggested by electrocar-
iographic changes and confirmed by elevation of cardiac
nzymes, regardless of symptoms. Respiratory failure was
efined as ventilator dependence of 72 hours, need for
ostoperative reintubation, clinical data or culture confir-
ation of pneumonia, or the need for tracheostomy. Ileus
as defined as a delay in gut motility lasting for more than
2 hours after surgery.12 Operative times, blood loss, and
ospital length of stay were also recorded and compared
etween groups.
Patients were followed up for overall survival and major
orbidity by means of office visits or telephone interviews.
Statistical analysis. Continuous variables were re-
orted as means and standard deviations, and P values were
alculated using unpaired t test or Mann-Whitney test, as
ppropriate. Dichotomous and other categorical variables
ere reported as percentages, and P values were calculated
sing the Fisher exact test. A P value .05 was considered
tatistically significant. A Kaplan-Meier method was used to
stimate survival. Comparison of actuarial survival accord-
ng to the study group, and to the CTP and MELD scores
as performed using the log-rank test. All statistical analy-
es were run using IBM SPSS Statistics 18 software (SPSS
nc, Chicago, Ill).
ESULTS
Analysis of demographics and risk factors not included
n the matching criteria showed that cirrhotics and controls
ere overall comparable (Table II). Twenty-two cirrhotic
atients were classified as CTP class A and two as CTP class
. Median MELD score was 8 (range, 6-14). Seventeen
atients had a MELD 10, and seven a MELD 10. In
etail, four patients had a MELD score equal to 6, four
atients had a MELD equal to 7, seven patients had a
ELD of 8, two had a MELD of 9, four had a MELD of
1, two had a MELD of 13, and one patient had a MELD
f 14.
Comparison of perioperative variables between cirrhot-
cs and controls are shown in Table III. Operative time was
ignificantly longer (162  49 vs 132  39 minutes; P 
007), intraoperative blood transfusion requirements were
hree-fold greater (273 364 vs 84 183 mL; P .040),
nd hospital length of stay was nearly doubled in cirrhotics
ompared to controls (11.0  2.8 vs 5.8  1.5 days; P 
0001; respectively). Among cirrhotic patients, CTP class B
atients required significantly more intraoperative blood
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April 2011908 Marrocco-Trischitta et altransfusions compared with CTP class A patients (941 54
vs 213  314 mL; P  .029).
No intraoperative or 30-day deaths were recorded. No
significant differences were found between groups in terms
of perioperative major morbidity (20.8% in cirrhotics vs
16.7% in controls; P  .749).
At a mean follow-up of 30.7  22.1 months, five
deaths were recorded in cirrhotics, and three in controls,
resulting in an actuarial survival at 2 years of 77.4% and
97.8%, respectively (log-rank test, P  .026; Fig 1).
Both CTP B patients died within 6 months due to
aneurysm-unrelated causes, namely as a consequence of
gastrointestinal bleeding. CTP class B and a MELD score
10 were significantly associated with reduced midterm
Table II. Comparison of patient demographics and preop
Overall
Gender
Male
Age
Mean  SD (years)
Abdominal aortic aneurysm diameter
Mean  SD (mm)
Preoperative glomerular filtration rate
Mean  SD (mL/min/1.73 m2)
Revised Cardiac Risk Index
I (0.5%)b
II (1.3%)b
III (3.6%)b
IV (9.1%)b
Hypertension
0 (Diastolic 90 mm Hg)
1 (Easily controlled, single drug)
2 (Requires two drugs)
3 (2 drugs or uncontrolled)
Diabetes
0 (None)
1 (Adult onset, no insulin)
2 (Adult onset, insulin controlled)
3 (Juvenile onset)
Smoking
0 (None or abstinence 10 years)
1 (None currently, abstinence 1-10 years)
2 (Current, 1 pack/day or abstinence 1 year)
3 (Current 1 pack/day)
Hyperlipidemia
0 (Cholesterol and triglycerides within normal limits for age)
1 (Mild elevation, diet controlled)
2 (Types II, III, or IV requiring strict diet control)
3 (Require drug control)
Pulmonary statusc
0
1
2
3
aFisher exact test or 2 test for categorical data; unpaired t test or Mann-Wh
bMajor cardiac complication rates.
cPulmonary status: 0  asymptomatic, normal chest X-ray film, pulmonar
changes, pulmonary function tests 65%-80%; 2 between 1 and 3; 3 vita
mm Hg, pulmonary hypertension.survival rates. More specifically, actuarial survival at 2 years aas 84.4% in CTP class A patients vs 0.0% in CTP class B
atients (log-rank test: P .0001; Fig 2), and was 90.0% in
atients with a MELD score10 vs 47.6% in patients with
MELD score 10 (log-rank test: P  .021, Fig 3).
ISCUSSION
Cirrhosis is a major cause of morbidity and mortality in
he U.S. and worldwide,4 and affected patients are increas-
ng in number due to the widespread hepatitis C virus-
elated liver disease, along with alcohol abuse.9 Also, as a
esult of the ongoing improvements and innovations in
edical therapy, the cirrhotic population is expected to
ge, and therefore the association of advanced liver disease
ve risk factors not included in the matching criteria
Cirrhotics, n
(%)
Controls, n
(%) Pa
24 48
23 (95.8) 46 (95.8) 1.0
68.2  6.9 68.8  6.4 .679
58.9  11.7 54.7  11.8 .090
86.7  26.8 82.8  24.5 .542
0 (0.0) 0 (0.0) .841
13 (54.2) 28 (58.3)
8 (33.3) 16 (33.3)
3 (12.5) 4 (8.3)
8 (33.3) 9 (18.7) .400
9 (37.5) 16 (33.3)
5 (20.8) 15 (31.2)
2 (8.3) 8 (16.7)
14 (58.3) 39 (81.2) .089
7 (29.2) 7 (14.6)
3 (12.5) 1 (2.1)
0 (0.0) 1 (2.1)
11 (45.8) 12 (25.0) .125
5 (20.8) 17 (35.4)
6 (25.0) 8 (16.7)
2 (8.3) 11 (22.9)
15 (62.5) 34 (70.8) .637
4 (16.7) 4 (8.3)
0 (0.0) 1 (2.1)
5 (20.8) 9 (18.7)
17 (70.8) 29 (60.4) .336
5 (20.8) 17 (35.4)
2 (8.3) 1 (2.1)
0 (0.0) 1 (2.1)
test for continuous data.
tion tests 20%; 1  mild dyspnea on exertion or mild X-ray parenchymal
ity1.85 L, forced expiratory volume in 1 s1.2 L or35%, pCO245erati
itney
y func
l capacnd AAA to become more common.
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Volume 53, Number 4 Marrocco-Trischitta et al 909In patients undergoing abdominal surgery, cirrhosis is
considered a dreadful challenge, and affected patients are
deemed at high risk, including those submitted to AAA
open repair,4 that also have an additional risk of perioper-
ative liver dysfunction in case of prolonged intraoperative
hypotension and pronouncedmetabolic acidosis.17 Consis-
tently, some authors have advocated endovascular aneu-
rysm repair (EVAR) for CTP Class B patients,18 and others
have considered CTP Class C patients at high risk, even
though not unfit for surgery.19
Our data show that relatively compensated cirrhotic
patients, defined by a MELD score of 18 or less,20 can be
submitted to elective AAA open repair with an acceptable
perioperative morbidity that should be employed as a
Table III. Comparison of perioperative variables of
interest
Cirrhotics
n (%)
Controls
n (%) Pa
Overall 24 48
Total operative time
Mean  SD (minutes) 162  49 132  39 .007
Blood transfusion
Mean  SD (mL) 273  364 84  183 .040
Hospital length of stay
Mean  SD (days) 11.0  2.8 5.8  1.5 .0001
Major complications
Total 5 (20.8) 8 (16.7) .749
Hepatic failure 1 (4.2) 0 (0.0)
Renal failure 0 (0.0) 1 (2.1)
Respiratory failure 1 (4.2) 4 (8.3)
Atrial fibrillation 2 (8.3) 1 (2.1)
Ileus 0 (0.0) 2 (4.2)
Lower limb ischemia 1 (4.2) 0 (0.0)
aFisher exact test or 2 test for categorical data; unpaired t test or Mann-
Whitney test for continuous data.
Fig 1. Actuarial survival at 2 years of cirrhotics versus controls
(77.4% vs 97.8%, respectively; log-rank test, P  .026). Standard
error bars are shown.benchmark for comparison with endovascular treatment. dn this respect, it is noteworthy that some authors cast
oubts regarding the suitability of cirrhotics for EVAR due
o the actual risk of the occurrence of acute disseminated
ntravascular coagulation induced by a worsening con-
umptive coagulopathy. Such a complication resulted to be
atal in at least three cirrhotic patients, two submitted to
VAR,21,22 and one to endovascular repair of a thoracic
ortic aneurysm (TEVAR).23 CTP scores were C and A,
espectively, in the two patients submitted to EVAR,
hereas this information was not provided for the patient
reated with TEVAR that was diagnosed with cirrhosis only
t autopsy.
Another important issue raised by our data is the rele-
ance of the prognosis of the affected patients in the
ig 2. Actuarial survival at 2 years of CTP class A patients (84.4%)
s CTP class B patients (0.0%; log-rank test, P .0001). Standard
rror bars are shown. CTP, Child-Turcotte-Pugh score.
ig 3. Actuarial survival of patients with a MELD score 10
90.0%) versus patients with a MELD score10 (47.6%; log-rank
est, P  .021). Standard error bars are shown.MELD, Model for
nd-Stage Liver Disease.ecision-making process. Cirrhotics have a reduced life
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April 2011910 Marrocco-Trischitta et alexpectancy as also showed by our data, and should be
treated not if they can survive surgery or EVAR, but if
treatment can provide them with an acceptable midterm
survival. For this purpose, in our paper we introduced the
use of MELD in patients with AAA. The MELD was
originally created at theMayoClinic as a prognostic tool for
patients submitted to transjugular intrahepatic portosys-
temic shunts (TIPS),24 and later validated in patients with
different degrees of liver disease. It incorporates three
widely available and objective laboratory variables, and can
be easily calculated online. The etiology of the liver disease,
initially included in the formula because it was prognosti-
cally relevant for patients undergoing TIPS, was later re-
moved as a variable because it was found to be less impor-
tant in different patient cohorts with cirrhosis.25
Since 2002, the MELD has been introduced as a crite-
rion to prioritized patients on the waiting list for liver
transplantation, replacing the CTP-based organ allocation
system that, by dividing patients in only three categories,
placed at a disadvantage extremely sick subjects only be-
cause they were listed late in their disease course.13 Of note,
the MELD turned out particularly useful in our study
group because it includes serum creatinine as a parameter,
which is an independent risk factor for mortality in patients
undergoing AAA repair.26
In our study, we employed a MELD score10 or10
as a cut-off, consistent with previous reports.27 A MELD
10 identifies patients that should not be listed for trans-
plantation, because the surgical risk exceeds that corre-
sponding to the natural history of the disease.28 Also,
patients with a MELD between 10 and 19 have been
reported to have a 6.0% mortality at 3 months, compared
with a 1.9% mortality of those with a MELD 9.11
Our data confirm that patients with a MELD10 have
a much lower expected survival at a midterm follow-up due
to causes unrelated of their aneurysm. As a consequence,
elective surgical repair of asymptomatic AAA does not
appear warranted in this subgroup of patients. Rather,
cirrhotics with a MELD 10 would probably be better
treated conservatively, as also previously recommended by
other authors regarding patients with large AAA associated
with serious comorbidities.29
In conclusion, we recognize some limitations of our
study, including the intrinsic biases related to its retrospec-
tive fashion, even though data were prospectively collected.
Also, due to the small number of patients, there may be
other significant variables that remained unrevealed as a
consequence of Type II errors. Nevertheless, we believe
that our work provides evidence that elective AAA open
repair can be performed quite safely in patients with cirrho-
sis relatively compensated.20 The poor midterm survival of
many of these patients, on the other hand, warrants an
accurate preoperative prognostic evaluation by means of
the MELD score, in order to identify those subjects that
may actually benefit from AAA repair. Nonoperative man-
agement should be considered for sicker patients on the
waiting list for liver transplantation. Of note, AAA repair,
whether open30 or endovascular,31 can be safely performedn liver transplant recipient, and an aggressive management
s warranted due to the typical more rapid rate of expansion
f AAA in these subjects.32
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